Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Malignant Ascites × 1 year × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 334 Neoplasms 303 Neoplasm Metastasis 260 Leukemia, Myeloid, Acute 254 Breast Neoplasms 251 Colorectal Neoplasms 207 Melanoma 177 Recurrence 173 Ovarian Neoplasms 173 Multiple Myeloma 161 Prostatic Neoplasms 144 Pancreatic Neoplasms 144 Lung Neoplasms 140 Lymphoma, Non-Hodgkin 133 Glioblastoma 132 Squamous Cell Carcinoma of Head and Neck 131 Triple Negative Breast Neoplasms 107 Brain Neoplasms 107 Glioma 104 Lymphoma, B-Cell 101 Myelodysplastic Syndromes 100 Carcinoma, Renal Cell 100 Advanced Solid Tumors 98 Lymphoma 94 Stomach Neoplasms 93 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Lymphoma, Large B-Cell, Diffuse 88 Carcinoma, Hepatocellular 88 Endometrial Neoplasms 86 Leukemia, Lymphocytic, Chronic, B-Cell 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07007988 2025-06-06

SIM0388-101

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting

Malignant Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡